["Snags" connected with establishing the vitamin D].

Serum 25-hydroxyvitamin D levels are commonly measured using immunoassays. These assays are widely used in clinical settings due to their speed and convenience. However, the accuracy and consistency of these methods remain uncertain. Prior research has shown that immunoassays can produce variable results when compared to reference methods like HPLC. This gap motivated the need for a detailed comparison of immunoassays against HPLC. The lack of standardization across immunoassays raises concerns about diagnostic reliability. No prior work had resolved the extent of variability among major brands. This uncertainty drives the need for clearer guidelines on acceptable differences. Understanding these discrepancies is essential for improving patient care and diagnostic accuracy.

This study aimed to evaluate the performance of three immunoassays—ABBOTT, ROCHE, and SIEMENS—against HPLC as a reference method. The goal was to assess the comparability of these immunoassays with each other and with HPLC. Researchers wanted to determine if these assays could be used interchangeably. The study also sought to evaluate the concordance in result interpretation. A key motivation was the lack of standardization in immunoassay measurements. The Vitamin D Standardization-Certification Program provided a benchmark for acceptable differences. The study aimed to highlight the need for assay-specific decision limits. This work contributes to improving the reliability of vitamin D testing in clinical practice.

The study used serum samples from 109 patients to measure 25-hydroxyvitamin D levels. Three immunoassays—ABBOTT, ROCHE, and SIEMENS—were compared to HPLC with UV detection. Researchers applied Passing-Bablok regression to assess linearity between methods. Bland-Altman analysis was used to evaluate agreement and bias. The maximum acceptable difference was set at 21.5% based on VDSCP guidelines. Immunoassays were compared both to HPLC and to each other. The interpretation of results was evaluated for concordance. This approach allowed for a comprehensive assessment of assay performance.

None of the immunoassays were comparable to HPLC or to each other. Bland-Altman analysis showed ROCHE had a positive bias of +28.0%. ABBOTT showed a small positive bias of +0.2%. SIEMENS had a negative bias of -23.4%. ABBOTT's average bias was not significant, but individual results varied widely. Some ABBOTT results deviated by as much as -89.4% to +89.0%. Concordance with HPLC was highest for ABBOTT at 65.21%. ROCHE had 59.63% concordance, and SIEMENS the lowest at 47.79%. These findings suggest poor standardization among immunoassays.

The study found that none of the immunoassays matched HPLC or each other in performance. The authors propose that current immunoassays lack sufficient standardization. They suggest using assay-specific decision limits to improve diagnostic accuracy. The findings highlight the need for greater consistency in vitamin D testing. The researchers emphasize the importance of reference methods like HPLC. They caution against assuming interchangeability between immunoassays. The results support the use of standardized protocols for result interpretation. These conclusions align with the authors' call for improved assay validation.